Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP183001.RAaBd-1YKdWXE7CTBDwJHlEv6zr5aH9I-iOzQ58enHDZw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP183001.RAaBd-1YKdWXE7CTBDwJHlEv6zr5aH9I-iOzQ58enHDZw130_assertion type Assertion NP183001.RAaBd-1YKdWXE7CTBDwJHlEv6zr5aH9I-iOzQ58enHDZw130_head.
- NP183001.RAaBd-1YKdWXE7CTBDwJHlEv6zr5aH9I-iOzQ58enHDZw130_assertion description "[Overall promoter methylation (OPM) in the SFRP2 gene was observed in one N and four T, whereas partial promoter methylation (PPM) was observed in two N and five T. OPM in the P16 gene was present in one T. In the DAPK1 gene, OPM existed in seven T and five N, while PPM was present in two N. In the HIC1 gene, OPM was demonstrated in three T, while PPM was noted in two N; however, no methylation existed in N. In the MGMT gene, OPM occurred in five T and two N, and PPM was present in one T. KRAS mutations in Turkish patients with SCRC are similar to those of other population groups.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP183001.RAaBd-1YKdWXE7CTBDwJHlEv6zr5aH9I-iOzQ58enHDZw130_provenance.
- NP183001.RAaBd-1YKdWXE7CTBDwJHlEv6zr5aH9I-iOzQ58enHDZw130_assertion evidence source_evidence_literature NP183001.RAaBd-1YKdWXE7CTBDwJHlEv6zr5aH9I-iOzQ58enHDZw130_provenance.
- NP183001.RAaBd-1YKdWXE7CTBDwJHlEv6zr5aH9I-iOzQ58enHDZw130_assertion SIO_000772 20682398 NP183001.RAaBd-1YKdWXE7CTBDwJHlEv6zr5aH9I-iOzQ58enHDZw130_provenance.
- NP183001.RAaBd-1YKdWXE7CTBDwJHlEv6zr5aH9I-iOzQ58enHDZw130_assertion wasDerivedFrom gad-20150221 NP183001.RAaBd-1YKdWXE7CTBDwJHlEv6zr5aH9I-iOzQ58enHDZw130_provenance.
- NP183001.RAaBd-1YKdWXE7CTBDwJHlEv6zr5aH9I-iOzQ58enHDZw130_assertion wasGeneratedBy ECO_0000203 NP183001.RAaBd-1YKdWXE7CTBDwJHlEv6zr5aH9I-iOzQ58enHDZw130_provenance.